« Back
Home /
PROTAC BET-binding moiety 2

PROTAC BET-binding moiety 2

Item no.	HY-43723-50mg
Manufacturer	MedChem Express
CASRN	916493-82-8
Amount	50 mg
Quantity options	100 mg 10 mM/1 mL 10 mg 25 mg 50 mg 5 mg
Category	Oncology By Cell Type Melanoma Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.77
Citations	[1]James E. Bradner, et al. Bivalent bromodomain inhibtors and uses thereof. WO2017091673A2.
Smiles	CC1=C(C(O)=O)SC2=C1C(C3=CC=C(Cl)C=C3)=N[C@@H](CC(OC)=O)C4=NN=C(C)N24
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	916493-82-8
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	Cancer-programmed cell death
Manufacturer - Targets	Ligands for Target Protein for PROTAC
Shipping Temperature	Room Temperature
Storage Conditions	-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight	444.89
Product Description	PROTAC BET-binding moiety 2 is an inhibitor of BET bromodomain[1].
Manufacturer - Research Area	Cancer
Solubility	DMSO: 42.86 mg/mL (ultrasonic)
Manufacturer - Pathway	PROTAC
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-43723-50mg-safety-datasheet.pdf